Get started Log in

LBPH — Longboard Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Brief: Longboard Pharmaceuticals Announces Initiation Of First-In-Human Phase 1 Clinical Study Of Lp659 In Adult Healthy Volunteers
29/11/2023 15:56
Longboard Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
02/11/2023 21:21
Longboard Pharmaceuticals Inc expected to post a loss of 70 cents a share - Earnings Preview
30/10/2023 17:19
Brief: Longboard Pharmaceuticals Completes Enrollment Of Phase 1B/2A Pacific Study Evaluating Lp352 For The Treatment Of Developmental And Epileptic Encephalopathies
23/08/2023 13:30
U.S. RESEARCH ROUNDUP-Autodesk, Bill Holdings, Zoetis
14/08/2023 08:18
Brief: Longboard Pharmaceuticals Inc Files For Mixed Shelf Of Up To $100 Million – SEC Filing
04/08/2023 21:12
Brief: Longboard Pharmaceuticals Q2 basic EPS USD -0.65
03/08/2023 22:13
Longboard Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
03/08/2023 21:55
Longboard Pharmaceuticals Inc expected to post a loss of 60 cents a share - Earnings Preview
31/07/2023 12:15
Brief: Longboard Pharmaceuticals Provides Corporate Update And Reports First Quarter 2023 Financial Results
09/05/2023 21:45
Longboard Pharmaceuticals Inc expected to post a loss of 57 cents a share - Earnings Preview
01/05/2023 13:45
Brief: Societal Cdmo Selected By Longboard Pharmaceuticals To Provide Cdmo Services To Support Clinical Development Of Lp352
05/04/2023 12:32
Longboard Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
02/03/2023 22:04
Brief: Longboard Pharmaceuticals Reports Full Year 2022 Financial Results And Key Corporate Initiatives
02/03/2023 21:28
Longboard Pharmaceuticals Inc expected to post a loss of 69 cents a share - Earnings Preview
28/02/2023 21:48
Brief: Longboard Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
08/02/2023 02:05
Brief: Longboard Pharmaceuticals Says Expects To Report That Cash, Cash Equivalents, Short-Term Investments As Of Dec. 31, 2022 Were About $67.6 Million
07/02/2023 21:52
Brief: Longboard Pharma Announces Commencement Of Public Offering Of Common Stock
07/02/2023 21:45
Brief: Longboard Pharmaceuticals Announces Positive Topline Data From Phase 1 Clinical Study Evaluating Central Nervous System Pharmacokinetics, Pharmacodynamics Of LP352 In Healthy Volunteers
05/12/2022 14:03
Longboard Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
03/11/2022 13:57